XPhyto Therapeutic Corporation (XPHYF) Corporate Media Kit

Bioscience Company with proven therapeutics and innovative diagnostics approaching the market. Made in Germany Diagnostics Lead product is a rapid point-of-care COVID-19 RT-PCR diagnostic test launched in Europe in April 2021. Diagnostic development pipeline includes a portfolio of real-time ultra low-cost infectious disease biosensors . Drug Delivery Platform technology to develop innovative cost- effective transdermal and oral dissolvable formulations of generic, hybrid-generic, and new active pharmaceutical ingredients. Drug Development 4 late-stage neurology therapeutics in clinical development and 2 psychedelic medicine programs. 4 Company Profile XPhyto Therapeutics Corporation A next generation bioscience company |